Joshua T Brumm
CIK 1528826 · Chief Executive Officer · last filed 2025-12-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.94M
Companies
5
Total Filings
44
Lifetime Open-Market Net
-$27.46M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Chief Executive Officer | 323,517 | $15.70 | $5.08M | $0 | 2 | 2025-12-17 |
| DYN | CEO & President | 546,616 | $18.19 | $9.94M | -$26.68M | 22 | 2024-03-12 |
| Kaleido Biosciences, Inc. (KLDO) Delisted | See Remarks | — | $0.29 | — | $0 | 1 | 2019-03-04 |
| Aravive, Inc. (VSAR) Delisted | COO and CFO | 201,269 | — | — | -$785.4K | 16 | 2017-10-23 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | VP of Corporate Development | 7,692 | — | — | $0 | 1 | 2012-04-30 |
Recent Filings · Page 3 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-14 | DYN | Grant (A) | +118,190 | $0 | EDGAR |
| 2021-10-04 | DYN | Gift (G) | −3,500 | $0 | EDGAR |
| 2021-09-22 | DYN | Sell (S) | −8,009 | -$127.3K | EDGAR |
| 2020-09-18 | DYN | Grant (A) | +107,027 | $0 | EDGAR |
| 2019-03-04 | Kaleido Biosciences, Inc. (KLDO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-23 | Aravive, Inc. (VSAR) Delisted | Sell (S) | −1,326 | -$3.4K | EDGAR |
| 2017-10-10 | Aravive, Inc. (VSAR) Delisted | Grant (A) | +97,000 | $0 | EDGAR |
| 2017-06-14 | Aravive, Inc. (VSAR) Delisted | Sell (S) | −1,421 | -$22.8K | EDGAR |
| 2017-05-17 | Aravive, Inc. (VSAR) Delisted | Sell (S) | −1,263 | -$22.0K | EDGAR |
| 2017-02-28 | Aravive, Inc. (VSAR) Delisted | Mixed | — | -$552.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.